175 related articles for article (PubMed ID: 35075140)
1. Galectin-1 as the new player in staging and prognosis of COVID-19.
Markovic SS; Gajovic N; Jurisevic M; Jovanovic M; Jovicic BP; Arsenijevic N; Mijailovic Z; Jovanovic M; Dolicanin Z; Jovanovic I
Sci Rep; 2022 Jan; 12(1):1272. PubMed ID: 35075140
[TBL] [Abstract][Full Text] [Related]
2. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
mBio; 2021 May; 12(3):. PubMed ID: 33947753
[TBL] [Abstract][Full Text] [Related]
3. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Galectin-1, Galectin-3, and Prostaglandin E2 Levels in Patients with COVID-19.
Kazancioglu S; Yilmaz FM; Bastug A; Ozbay BO; Aydos O; Yücel Ç; Bodur H; Yilmaz G
Jpn J Infect Dis; 2021 Nov; 74(6):530-536. PubMed ID: 33790073
[TBL] [Abstract][Full Text] [Related]
5. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
Front Immunol; 2021; 12():668725. PubMed ID: 34276659
[TBL] [Abstract][Full Text] [Related]
6. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
[TBL] [Abstract][Full Text] [Related]
7. Galectin-3 as an important prognostic marker for COVID-19 severity.
Gajovic N; Markovic SS; Jurisevic M; Jovanovic M; Arsenijevic N; Mijailovic Z; Jovanovic M; Jovanovic I
Sci Rep; 2023 Jan; 13(1):1460. PubMed ID: 36702907
[TBL] [Abstract][Full Text] [Related]
8. Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis.
Bergantini L; d'Alessandro M; Cameli P; Otranto A; Luzzi S; Bianchi F; Bargagli E
Cytokine; 2022 Mar; 151():155804. PubMed ID: 35063722
[TBL] [Abstract][Full Text] [Related]
9. Cytokine profile and disease severity in patients with COVID-19.
Ghazavi A; Ganji A; Keshavarzian N; Rabiemajd S; Mosayebi G
Cytokine; 2021 Jan; 137():155323. PubMed ID: 33045526
[TBL] [Abstract][Full Text] [Related]
10. Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.
Li J; Wei J; Xu Z; Jiang C; Li M; Chen J; Li Y; Yang M; Gu Y; Wang F; Shu Y; Yang Y; Sun L; Liu Y
Front Immunol; 2021; 12():691879. PubMed ID: 34163488
[TBL] [Abstract][Full Text] [Related]
11. A unique maternal and placental galectin signature upon SARS-CoV-2 infection suggests galectin-1 as a key alarmin at the maternal-fetal interface.
Zhao F; Tallarek AC; Wang Y; Xie Y; Diemert A; Lu-Culligan A; Vijayakumar P; Kittmann E; Urbschat C; Bayo J; Arck PC; Farhadian SF; Dveksler GS; Garcia MG; Blois SM
Front Immunol; 2023; 14():1196395. PubMed ID: 37475853
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19.
Satış H; Özger HS; Aysert Yıldız P; Hızel K; Gulbahar Ö; Erbaş G; Aygencel G; Guzel Tunccan O; Öztürk MA; Dizbay M; Tufan A
Cytokine; 2021 Jan; 137():155302. PubMed ID: 33002740
[TBL] [Abstract][Full Text] [Related]
13. Prognostic bioindicators in severe COVID-19 patients.
Bergantini L; Bargagli E; d'Alessandro M; Refini RM; Cameli P; Galasso L; Scapellato C; Montagnani F; Scolletta S; Franchi F; Valente S; Bennett D; Sebastiani G; Frediani B; Dotta F
Cytokine; 2021 May; 141():155455. PubMed ID: 33548798
[TBL] [Abstract][Full Text] [Related]
14. Circulatory Cytokine Levels as a Predictor of Disease Severity in COVID-19: A Study from Western India.
Bhandari S; Rankawat G; Mathur S; Kumar A; Sahlot R; Jain A
J Assoc Physicians India; 2022 May; 70(5):11-12. PubMed ID: 35598128
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19.
Ling L; Chen Z; Lui G; Wong CK; Wong WT; Ng RWY; Tso EYK; Fung KSC; Chan V; Yeung ACM; Hui DSC; Chan PKS
Front Immunol; 2021; 12():763292. PubMed ID: 34938289
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 is associated with severe heart failure and death: A hospital-based study in Chinese patients.
Wang N; Dang M; Zhang W; Lei Y; Liu Z
Scand J Immunol; 2020 May; 91(5):e12826. PubMed ID: 31514240
[TBL] [Abstract][Full Text] [Related]
17. High serum IL-6 values increase the risk of mortality and the severity of pneumonia in patients diagnosed with COVID-19.
Guirao JJ; Cabrera CM; Jiménez N; Rincón L; Urra JM
Mol Immunol; 2020 Dec; 128():64-68. PubMed ID: 33075636
[TBL] [Abstract][Full Text] [Related]
18. Gal-3BP in Viral Infections: An Emerging Role in Severe Acute Respiratory Syndrome Coronavirus 2.
Gallo V; Arienzo A; Iacobelli S; Iacobelli V; Antonini G
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806317
[TBL] [Abstract][Full Text] [Related]
19. The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical).
Ghofrani Nezhad M; Jami G; Kooshkaki O; Chamani S; Naghizadeh A
J Interferon Cytokine Res; 2023 Apr; 43(4):147-163. PubMed ID: 37062817
[TBL] [Abstract][Full Text] [Related]
20. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
